sevuparin
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02515838)
Timeline
Indications
Mechanism of action
- HeparinSupplementation
Heparin supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sevuparin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03853421 | Phase 1 | Feb 6, 2019 | Modus Therapeutics AB |
| NCT02515838 | Phase 2 | Jul 1, 2015 | Ergomed, Modus Therapeutics AB |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Modus Therapeutics AB | For profit | 2 | 2 | 2 | 2015 |
| Ergomed | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1